InterMune rebounds; AEterna rallies
May 06, 2010 at 10:40 AM EDT
Shares of InterMune Inc. are on the rebound in early trading, the day after its stock plunged almost 80% following a regulatory setback for its new lung-disease medication Esbriet.
